vs
Astrana Health, Inc.（ASTH）与OCEANEERING INTERNATIONAL INC（OII）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是OCEANEERING INTERNATIONAL INC的1.4倍（$950.5M vs $692.4M），OCEANEERING INTERNATIONAL INC净利率更高（5.2% vs 0.7%，领先4.5%），Astrana Health, Inc.同比增速更快（42.9% vs 3.6%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-76.5M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 1.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
奥什科什国际（Oceaneering International）是一家总部位于美国得克萨斯州休斯敦的水下工程及应用技术企业，为海洋、航天及其他特殊作业场景的客户提供定制化工程服务与硬件设备，在极端环境工程领域拥有深厚的技术积累。
ASTH vs OII — 直观对比
营收规模更大
ASTH
是对方的1.4倍
$692.4M
营收增速更快
ASTH
高出39.3%
3.6%
净利率更高
OII
高出4.5%
0.7%
自由现金流更多
ASTH
多$70.6M
$-76.5M
两年增速更快
ASTH
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $692.4M |
| 净利润 | $6.6M | $36.1M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 5.2% |
| 营收同比 | 42.9% | 3.6% |
| 净利润同比 | 184.4% | -28.3% |
| 每股收益（稀释后） | $0.12 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHOII
| Q1 26 | — | $692.4M | ||
| Q4 25 | $950.5M | $668.6M | ||
| Q3 25 | $956.0M | $742.9M | ||
| Q2 25 | $654.8M | $698.2M | ||
| Q1 25 | $620.4M | $674.5M | ||
| Q4 24 | $665.2M | $713.5M | ||
| Q3 24 | $478.7M | $679.8M | ||
| Q2 24 | $486.3M | $668.8M |
净利润ASTHOII
| Q1 26 | — | $36.1M | ||
| Q4 25 | $6.6M | $177.7M | ||
| Q3 25 | $373.0K | $71.3M | ||
| Q2 25 | $9.4M | $54.4M | ||
| Q1 25 | $6.7M | $50.4M | ||
| Q4 24 | $-7.8M | $56.1M | ||
| Q3 24 | $16.1M | $41.2M | ||
| Q2 24 | $19.2M | $35.0M |
毛利率ASTHOII
| Q1 26 | — | — | ||
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.3% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 18.0% |
营业利润率ASTHOII
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 9.8% | ||
| Q3 25 | 2.0% | 11.6% | ||
| Q2 25 | 3.1% | 11.3% | ||
| Q1 25 | 3.3% | 10.9% | ||
| Q4 24 | 0.1% | 10.9% | ||
| Q3 24 | 5.9% | 10.5% | ||
| Q2 24 | 6.2% | 9.0% |
净利率ASTHOII
| Q1 26 | — | 5.2% | ||
| Q4 25 | 0.7% | 26.6% | ||
| Q3 25 | 0.0% | 9.6% | ||
| Q2 25 | 1.4% | 7.8% | ||
| Q1 25 | 1.1% | 7.5% | ||
| Q4 24 | -1.2% | 7.9% | ||
| Q3 24 | 3.4% | 6.1% | ||
| Q2 24 | 3.9% | 5.2% |
每股收益（稀释后）ASTHOII
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.12 | $1.75 | ||
| Q3 25 | $0.01 | $0.71 | ||
| Q2 25 | $0.19 | $0.54 | ||
| Q1 25 | $0.14 | $0.49 | ||
| Q4 24 | $-0.14 | $0.55 | ||
| Q3 24 | $0.33 | $0.40 | ||
| Q2 24 | $0.40 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | — |
| 总债务越低越好 | — | $488.8M |
| 股东权益账面价值 | $779.3M | $1.1B |
| 总资产 | $2.2B | $2.6B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资ASTHOII
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | $695.9M | ||
| Q3 25 | $463.4M | $7.0M | ||
| Q2 25 | $342.1M | $7.0M | ||
| Q1 25 | $260.9M | $7.0M | ||
| Q4 24 | $290.8M | $504.5M | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — |
总债务ASTHOII
| Q1 26 | — | $488.8M | ||
| Q4 25 | — | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASTHOII
| Q1 26 | — | $1.1B | ||
| Q4 25 | $779.3M | $1.1B | ||
| Q3 25 | $775.5M | $907.7M | ||
| Q2 25 | $765.5M | $842.1M | ||
| Q1 25 | $745.4M | $773.1M | ||
| Q4 24 | $712.7M | $714.3M | ||
| Q3 24 | $704.6M | $698.0M | ||
| Q2 24 | $678.9M | $651.0M |
总资产ASTHOII
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.2B | $2.7B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | $1.3B | $2.3B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.3B |
负债/权益比ASTHOII
| Q1 26 | — | 0.44× | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-76.5M |
| 自由现金流率自由现金流/营收 | -0.6% | -11.1% |
| 资本支出强度资本支出/营收 | 0.3% | 2.5% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $238.1M |
8季度趋势，按日历期对齐
经营现金流ASTHOII
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $221.1M | ||
| Q3 25 | $10.0M | $101.3M | ||
| Q2 25 | $90.9M | $77.2M | ||
| Q1 25 | $16.6M | $-80.7M | ||
| Q4 24 | $-10.9M | $128.4M | ||
| Q3 24 | $34.0M | $91.9M | ||
| Q2 24 | $23.2M | $52.6M |
自由现金流ASTHOII
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $-6.0M | $190.7M | ||
| Q3 25 | $7.4M | $77.0M | ||
| Q2 25 | $89.5M | $46.9M | ||
| Q1 25 | $13.6M | $-106.8M | ||
| Q4 24 | $-13.5M | $94.5M | ||
| Q3 24 | $31.7M | $67.0M | ||
| Q2 24 | $20.4M | $29.8M |
自由现金流率ASTHOII
| Q1 26 | — | -11.1% | ||
| Q4 25 | -0.6% | 28.5% | ||
| Q3 25 | 0.8% | 10.4% | ||
| Q2 25 | 13.7% | 6.7% | ||
| Q1 25 | 2.2% | -15.8% | ||
| Q4 24 | -2.0% | 13.2% | ||
| Q3 24 | 6.6% | 9.9% | ||
| Q2 24 | 4.2% | 4.5% |
资本支出强度ASTHOII
| Q1 26 | — | 2.5% | ||
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.3% | 3.3% | ||
| Q2 25 | 0.2% | 4.3% | ||
| Q1 25 | 0.5% | 3.9% | ||
| Q4 24 | 0.4% | 4.7% | ||
| Q3 24 | 0.5% | 3.7% | ||
| Q2 24 | 0.6% | 3.4% |
现金转化率ASTHOII
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.24× | ||
| Q3 25 | 26.69× | 1.42× | ||
| Q2 25 | 9.65× | 1.42× | ||
| Q1 25 | 2.48× | -1.60× | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | 2.11× | 2.23× | ||
| Q2 24 | 1.21× | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
OII
暂无分部数据
